TYSABRI 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

Biogen Netherlands B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 91f295ab7b81fb6f
Drug Cima Aemps Name: TYSABRI 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number: 106346002
Holder Company Name: Biogen Netherlands B.V.
Marketing Company Name: Biogen Spain S.L.
Holder Company Detail Path: /organization/biogen-netherlands-bv
Authorization Date: 2021-04-21
Dosage Form: SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 150 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Biogen Netherlands B.V.
Company Detail Path: /organization/biogen-netherlands-bv

NATALIZUMAB

150 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 21, 2021

Approval ID

91f295ab7b81fb6f

Type

Standard